# ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar

> **NCT06997055** · — · RECRUITING · sponsor: **Celltrion HealthCare France** · enrollment: 225 (estimated)

## Conditions studied

- Crohn Disease
- Plaque Psoriasis

## Interventions

- **DRUG:** Ustekinumab 45 mg
- **DRUG:** Ustekinumab 90 mg

## Key facts

- **NCT ID:** NCT06997055
- **Lead sponsor:** Celltrion HealthCare France
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-17
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2025-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06997055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06997055, "ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06997055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*